Innovaderm Research Inc. is a specialized Contract Research Organization (CRO) founded in 2000 by Dr. Robert Bissonnette, headquartered in Montreal, Canada. The company focuses primarily on clinical research in dermatology and rheumatology, supporting pharmaceutical and biotech companies in the management of clinical trials from Phase I through Phase IV. It is recognized for its commitment to advancing new therapies for skin diseases, aiding patients in accessing effective treatments.

With over two decades of experience, Innovaderm has built a strong reputation for high-quality clinical research services, particularly in conditions such as psoriasis, acne, and atopic dermatitis. The firm operates a dedicated research clinic and maintains an extensive network of clinical sites across North America and Europe, enabling efficient multicenter trials. Their multidisciplinary team includes experts in life sciences and clinical research who focus on ensuring patient care and regulatory compliance.

Innovaderm emphasizes innovation in research methodologies and operational efficiency to remain at the forefront of dermatologic clinical research. The company prioritizes client satisfaction and quality across its collaborations with sponsors, research sites, and study participants. It fosters a culture of teamwork, accountability, and solution-oriented approaches to deliver value and impact in the development of new dermatological therapies.

The organization also highlights its dedication to patient care during clinical studies, with experienced study coordinators, lab technicians, and research nurses providing attentive support throughout the research process. With a medical leadership team that includes experts such as Dr. Catherine Maari, Innovaderm continues to contribute significantly to dermatology research and clinical trials.

Overall, Innovaderm Research Inc. serves as a global partner to biopharmaceutical companies by offering comprehensive clinical research services and leveraging data analytics to enhance trial outcomes in dermatology and rheumatology.